Durable Responses in Patients Treated with Galiximab (Anti-CD80) in Combination with Rituximab for Relapsed or Refractory Follicular Lymphoma: Long-Term Follow-up of a Phase II Clinical Trial.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Friedberg, JW; Younes, A; Fisher, DC; Gordon, LI; Moore, JO; Czuczman, MS; Miller, TP; Stiff, PJ; Cheson, BD; Forero-Torres, A; McKinney, B; Leonard, JP

Published Date

  • November 16, 2008

Published In

Volume / Issue

  • 112 / 11

Start / End Page

  • 369 - 370

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 50th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • San Francisco, CA

Conference Start Date

  • December 6, 2008

Conference End Date

  • December 9, 2008